Vitasora Health Limited
VHLUF
$0.0581
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 533.33% | 547.20% | 370.05% | 358.56% | 1,400.00% |
| Total Other Revenue | 5.12% | 7.56% | -- | -- | -1.86% |
| Total Revenue | 111.74% | 116.76% | 370.05% | 358.56% | 20.98% |
| Cost of Revenue | 7,507.69% | 7,723.08% | -101.52% | -101.49% | -91.39% |
| Gross Profit | 71.13% | 75.06% | 575.50% | 556.77% | 30.28% |
| SG&A Expenses | 28.57% | 31.58% | 32.14% | 28.89% | 32.46% |
| Depreciation & Amortization | -66.32% | -65.75% | -166.94% | -165.35% | 120.45% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.52% | 37.66% | 29.14% | 25.95% | 20.21% |
| Operating Income | -16.48% | -19.21% | -22.18% | -19.16% | -20.04% |
| Income Before Tax | -14.17% | -16.85% | -21.61% | -18.60% | -22.55% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.17% | -16.85% | -21.61% | -18.60% | -22.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.17% | -16.85% | -21.61% | -18.60% | -22.55% |
| EBIT | -16.48% | -19.21% | -22.18% | -19.16% | -20.04% |
| EBITDA | -18.92% | -21.70% | -22.19% | -18.78% | -18.46% |
| EPS Basic | 9.09% | 16.67% | 15.38% | 15.38% | 0.00% |
| Normalized Basic EPS | 14.29% | 14.29% | 12.50% | 12.50% | 0.00% |
| EPS Diluted | 9.09% | 16.67% | 7.69% | 7.69% | 0.00% |
| Normalized Diluted EPS | 14.29% | 14.29% | 12.50% | 12.50% | 0.00% |
| Average Basic Shares Outstanding | 33.92% | 33.92% | 35.67% | 35.67% | 16.06% |
| Average Diluted Shares Outstanding | 33.92% | 33.92% | 35.67% | 35.67% | 16.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |